Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299)
Sponsored by Organon and Co
About this trial
Last updated 3 years ago
Study ID
Status
Type
Placebo
Accepting
Not accepting
Trial Timing
Ended 18 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Children patients of both sexes aged between 2-11 years, of either gender and any race
- Unequivocal history of perennial allergic rhinitis, including nasal congestion, sneezing, rhinorrhea, pruritus, and lacrimation
- Minimum score for inclusion: 10
- Capable of complying with the dosing regimen
- Free of any clinically significant disease (other than allergic rhinitis)
- Antihistamine must be justified by investigating doctor
Exclusion Criteria
- Patients with asthma who require chronic use of inhaled or systemic corticosteroids
- History of frequent, clinically significant sinusitis or chronic purulent postnasal drip
- Patients with rhinitis medicamentosa
- History of hypersensitivity to desloratadine or any of its excipients
- Doctor deems unsuitable